TIVITY HEALTH, INC. TVTY Cash Flow

Tivity health, inc. (TVTY)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09
Cash flows from operating activities:
Income (loss) from continuing operations
-286,821	97,902	61,230	56,091	43,634	42,836	-	-	-	-	-
Income from discontinued operations
-	901	2,485	-184,706	-74,952	-48,397	-	-	-	-	-
Net income (loss)
-	-	-	-	-	-	-8,541	8,024	-157,693	47,330	10,374
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
50,775	4,667	3,357	31,292	49,855	-53,378	52,791	51,734	49,988	52,756	49,289
Amortization and write-off of deferred loan costs
4,487	1,152	2,887	-	-	-	-	-	-	-	-
Amortization of deferred loan costs
-	-	-	2,209	2,520	1,855	1,685	2,284	1,894	1,827	1,518
Amortization of debt discount
3,711	4,140	8,001	7,564	7,148	6,757	3,140	0	0	-	-
Share-based employee compensation expense
18,832	6,097	6,658	17,538	10,469	8,349	7,116	6,371	9,246	11,450	10,213
Gain on sale of investment
-	-	-	-	-	-	-	-	-	1,163	2,581
Impairment of goodwill and intangible assets
377,100	-	-	-	-	-	-	-	183,288	0	0
Loss on sale of MeYou Health
-	-	-	-	0	0	0	-	-	-	-
(Gain) loss on sale of TPHS business
-	-	-	-	0	0	-	-	-	-	-
Gain on sale of navvis business
-	-	-	-	1,873	0	-	-	-	-	-
Loss on release of cumulative translation adjustment
-	-	-3,044	-	0	-	-	-	-	-	-
Equity in income from joint ventures
-	-	-	271	-20,229	0	0	-	-	-	-
Deferred income taxes
-52,076	25,485	40,935	-75,942	-5,916	-6,972	-5,077	-1,334	-3,572	16,682	8,076
Excess tax benefits from share-based payment arrangements
-	-	-	-	-	525	718	492	433	1,067	381
Decrease (increase) in accounts receivable, net
8,283	12,311	3,939	-8,330	-16,971	38,130	-19,099	23,439	7,452	-12,207	-14,352
Decrease in inventory
-2,087	-	-	-	-	-	-	-	-	-	-
Decrease in other current assets
426	-1,610	-820	-2,819	-2,796	-1,589	598	-2,984	-6,960	159	1,972
Increase in accounts payable
-10,052	-95	-407	-3,376	5,248	-9,343	9,224	-995	1,466	-2,256	6,565
Decrease in accrued salaries and benefits
3,608	-10,314	-6,061	-1,056	-801	3,165	-5,780	-12,980	-8,932	-19,715	24,991
Increase in other current liabilities
-21,495	-11,802	-6,436	-4,825	-11,764	26,990	-1,196	13,637	2,676	-45,206	-11,067
Increase in deferred revenue
-1,198	-	-	-	-	-	-	-	-	-	-
Other
2,056	2,611	-2,565	-7,425	940	10,546	383	-5,096	-1,144	201	3,491
Net cash flows provided by operating activities
82,305	108,739	105,276	45,601	64,504	52,098	71,528	40,698	76,292	72,887	112,868
Cash flows from investing activities:
Acquisition of property and equipment
24,713	9,053	5,910	14,474	34,730	42,991	41,346	48,912	49,290	44,431	49,110
Investment in joint ventures
-	-	-	1,298	5,881	7,050	6,507	0	-	-	-
Proceeds from sale of MeYou Health
-	1,416	-	5,156	0	0	0	-	-	-	-
Proceeds From sale of navvis
-	-	-	-	4,369	0	-	-	-	-	-
Payments related to sale of TPHS business
-	-	-	27,469	0	0	-	-	-	-	-
Sale of investment
-	-	-	-	-	-	-	-	-	-1,163	-11,626
Business acquisitions, net of cash acquired
1,062,818	-	-	-	-	-	830	4,693	23,523	0	19,486
Other
-	-	-	787	1,121	1,164	1,210	6,872	6,889	5,581	5,456
Net cash flows used in investing activities
-1,087,531	-7,637	-5,910	-38,872	-37,363	-51,205	-49,893	-60,477	-79,702	-48,849	-62,426
Cash flows from financing activities:
Proceeds from issuance of long-term debt
1,611,970	253,425	373,450	515,666	572,981	467,126	352,850	755,550	439,621	656,997	405,400
Payments of long-term debt
574,329	373,536	449,084	527,115	597,837	481,515	529,874	736,355	417,490	673,188	457,303
Proceeds from settlement of cash convertible notes hedges
-	141,246	-	-	-	-	-	-	-	-	-
Proceeds from non-controlling interest
-	-	-	-	1,615	0	0	-	-	-	-
Proceeds from cash convertible senior notes
-	-	-	-	-	-	150,000	0	0	-	-
Proceeds from convertible note
-	-	-	-	-	-	20,000	0	0	-	-
Proceeds from sale of warrants
-	-	-	-	-	-	15,150	0	0	-	-
Payments related to settlement of cash conversion derivative
-	141,246	-	-	-	-	36,750	0	0	-	-
Payments related to tax withholding for share-based compensation
4,733	9,762	4,481	7,699	3,544	-	-	-	-	-	-
Repurchase of stock options
-	-	-	-	-	-	-	-	-	-	736
Excess tax benefits from share-based payment arrangements
-	-	-	-	-	525	718	492	433	1,067	381
Exercise of stock options
1,000	1,910	5,722	10,002	2,467	2,851	12,748	2,835	4,825	1,133	727
Repurchase of common stock
-	-	-	-	1,833	0	0	-	23,690	4,494	0
Deferred loan costs
30,189	-	2,452	424	892	391	5,264	2,547	0	3,219	784
Principal payments related to financing leases
274	-	-	-	-	-	-	-	-	-	-
Change in cash overdraft and other
2,357	410	2,533	2,834	1,648	11,227	526	582	-709	-3,717	-1,113
Net cash flows provided by financing activities
1,005,791	-127,553	-74,312	-6,736	-25,395	-177	-19,896	20,557	2,990	-25,421	-53,428
Effect of exchange rate changes on cash
-12	-56	1,784	-261	-1,641	-1,535	-914	117	220	91	185
Less: net (decrease) increase in discontinued operations cash and cash equivalents
-	-	-	1,637	-388	347	-	-	-	-	-
Net increase in cash and cash equivalents
553	-26,507	26,838	1,369	-283	-472	825	895	-200	-1,292	-2,801
Supplemental disclosure of cash flow information:
Cash paid for interest
67,717	4,099	4,727	7,474	8,303	9,503	10,080	12,001	11,106	12,137	12,717
Cash paid for income taxes, net of refunds
8,370	3,339	-	1,458	262	2,399	650	2,282	7,874	13,231	18,390
Issuance of CareFirst Warrants
-	-	-	192	2,408	1,639	0	-	-	-	-
Assets acquired through capital lease obligation
-	-	-	-	898	6,702	0	0	-	8,435	0
Conversion of CareFirst Convertible Note
-	-	-	20,000	0	0	-	-	-	-	-
Issuance of unregistered common stock associated with Navvis acquisition
-	-	-	-	-	-	-	-	3,262	0	0
Issuance of unregistered common stock associated with Ascentia acquisition
-	-	-	-	-	-	-	58	0	0	-
Issuance of unregistered common stock associated with Ornish partnership
-	-	-	-	-	-	467	0	0	-	-
MeYou Health
(Gain) loss on sale
-	1,416	-	-5,325	-	-	-	-	-	-	-
TPHS Business
(Gain) loss on sale
-	-112	4,733	-192,034	-	-	-	-	-	-	-